UNITED THERAPEUTICS Corp - Common Stock (UTHR) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2014 to Q4 2025

Type / Class
Equity / Common Stock
Symbol
UTHR on Nasdaq
Shares outstanding
44,798,018
Price per share
$487.25
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
40,876,222
Total reported value
$17,137,933,444
% of total 13F portfolios
0.02%
Share change
-2,995,001
Value change
-$1,069,504,988
Number of holders
694
Price from insider filings
$487.25
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of UNITED THERAPEUTICS Corp - Common Stock (UTHR) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
STATE STREET CORP 4.9% $661,670,195 2,199,994 STATE STREET CORPORATION 31 Dec 2024
WELLINGTON MANAGEMENT GROUP LLP 4.5% -17% $609,464,876 -$131,574,981 2,026,416 -18% Wellington Management Group LLP 31 Mar 2025

As of 30 Sep 2025, 694 institutional investors reported holding 40,876,222 shares of UNITED THERAPEUTICS Corp - Common Stock (UTHR). This represents 91% of the company’s total 44,798,018 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of UNITED THERAPEUTICS Corp - Common Stock (UTHR) together control 61% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
BlackRock, Inc. 12% 5,352,996 +0.36% 0.04% $2,244,029,549
VANGUARD GROUP INC 9.9% 4,418,610 -0.68% 0.03% $1,852,325,498
RENAISSANCE TECHNOLOGIES LLC 4.9% 2,173,392 +2.6% 1.2% $911,107,660
Avoro Capital Advisors LLC 4.5% 2,022,222 -15% 11% $847,735,685
STATE STREET CORP 4.3% 1,922,609 -11% 0.03% $805,976,919
WELLINGTON MANAGEMENT GROUP LLP 3.1% 1,398,781 -3.1% 0.1% $586,382,984
GEODE CAPITAL MANAGEMENT, LLC 2.8% 1,249,660 +4.1% 0.03% $522,908,608
AQR CAPITAL MANAGEMENT LLC 2.2% 986,478 -23% 0.27% $413,541,523
Darwin Global Management, Ltd. 1.7% 748,550 8.8% $317,617,251
LSV ASSET MANAGEMENT 1.5% 686,710 -21% 0.64% $287,876,000
ASSETMARK, INC 1.4% 645,908 -9.8% 0.58% $270,771,197
Invesco Ltd. 1.4% 637,223 -28% 0.04% $267,130,253
CITIGROUP INC 1.2% 551,470 +1197% 0.16% $231,181,739
DIMENSIONAL FUND ADVISORS LP 1.1% 512,816 -11% 0.05% $214,994,809
JANUS HENDERSON GROUP PLC 1% 454,718 +62% 0.09% $190,569,761
NORTHERN TRUST CORP 1% 447,018 -1.2% 0.02% $187,394,415
MORGAN STANLEY 0.98% 438,803 +10% 0.01% $183,951,225
DEERFIELD MANAGEMENT COMPANY, L.P. 0.95% 425,993 -21% 2.7% $178,580,526
Bank of New York Mellon Corp 0.78% 351,455 -3% 0.03% $147,333,387
Pacer Advisors, Inc. 0.76% 339,071 -33% 0.36% $142,141,954
Swedbank AB 0.73% 329,118 -0.45% 0.14% $137,969,558
Pictet Asset Management Holding SA 0.72% 321,495 +52% 0.13% $134,870,472
FULLER & THALER ASSET MANAGEMENT, INC. 0.7% 315,305 -19% 0.45% $132,178,929
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 0.7% 312,948 -6.8% 0.02% $131,190,931
PRICE T ROWE ASSOCIATES INC /MD/ 0.67% 300,931 +163% 0.01% $126,154,000

Institutional Holders of UNITED THERAPEUTICS Corp - Common Stock (UTHR) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 115,524 $56,682,071 +$14,819,350 $487.25 35
2025 Q3 40,876,222 $17,137,933,444 -$1,069,504,988 $419.21 694
2025 Q2 43,924,518 $12,621,620,981 -$132,393,705 $287.35 662
2025 Q1 44,441,020 $13,691,236,526 +$58,445,640 $308.27 661
2024 Q4 43,992,356 $15,526,430,783 +$60,965,879 $352.84 667
2024 Q3 43,520,361 $15,594,079,368 -$719,584,018 $358.35 617
2024 Q2 45,751,455 $14,568,456,882 +$331,436,428 $318.55 557
2024 Q1 45,081,525 $10,361,695,587 +$141,369,039 $229.72 518
2023 Q4 44,516,671 $9,786,687,446 +$24,490,915 $219.89 528
2023 Q3 44,424,001 $10,034,347,626 -$137,617,629 $225.87 503
2023 Q2 44,929,853 $9,916,555,660 -$53,987,464 $220.75 466
2023 Q1 45,106,269 $10,099,164,591 -$14,220,192 $223.96 499
2022 Q4 44,906,712 $12,485,251,712 +$52,130,518 $278.09 506
2022 Q3 44,754,285 $9,370,900,072 +$62,537,202 $209.38 450
2022 Q2 44,045,171 $10,378,944,055 +$127,464,630 $235.64 462
2022 Q1 44,003,492 $7,893,754,591 +$134,402,123 $179.41 416
2021 Q4 43,119,761 $9,315,950,531 -$262,053,365 $216.08 409
2021 Q3 44,131,602 $8,148,234,087 +$112,030,536 $184.58 415
2021 Q2 43,453,740 $7,794,694,945 +$9,014,738 $179.41 397
2021 Q1 43,411,843 $7,268,500,823 +$26,763,473 $167.27 384
2020 Q4 43,003,015 $6,528,125,218 +$196,460,628 $151.79 347
2020 Q3 41,894,495 $4,231,829,902 -$29,144,918 $101.00 320
2020 Q2 42,050,372 $5,086,767,081 -$63,243,154 $121.00 338
2020 Q1 42,930,204 $4,071,608,811 +$175,279,566 $94.83 293
2019 Q4 41,222,454 $3,630,167,945 -$10,769,148 $88.08 313
2019 Q3 41,360,375 $3,298,822,179 -$43,165,509 $79.75 293
2019 Q2 41,925,901 $3,270,999,774 -$120,924,183 $78.06 310
2019 Q1 42,851,966 $5,019,717,224 -$2,500,101 $117.37 365
2018 Q4 42,797,039 $4,647,344,925 -$44,377,540 $108.90 349
2018 Q3 42,931,668 $5,477,659,096 +$109,487,455 $127.88 358
2018 Q2 42,156,011 $4,759,186,005 -$156,681,448 $113.15 363
2018 Q1 43,460,877 $4,868,793,558 -$69,339 $112.36 365
2017 Q4 43,844,012 $6,467,580,193 +$1,702,122 $147.95 396
2017 Q3 43,668,487 $5,125,733,185 -$334,513,080 $117.19 366
2017 Q2 46,301,037 $6,009,612,999 -$200,410,807 $129.73 370
2017 Q1 47,751,240 $6,465,099,833 +$610,508,007 $135.38 403
2016 Q4 47,458,415 $6,801,787,668 -$130,023,048 $143.43 399
2016 Q3 48,612,849 $5,737,572,105 -$95,788,438 $118.08 386
2016 Q2 49,467,005 $5,240,809,009 -$126,453,122 $105.92 376
2016 Q1 50,901,388 $5,672,819,733 -$72,469,397 $111.43 392
2015 Q4 51,032,866 $7,993,767,829 +$6,715,778 $156.61 379
2015 Q3 50,877,238 $6,677,428,627 -$88,605,466 $131.24 364
2015 Q2 51,009,203 $8,872,097,786 -$239,100,161 $173.95 382
2015 Q1 52,380,211 $9,025,014,777 +$258,920,695 $172.43 364
2014 Q4 51,016,976 $6,610,861,799 -$258,272,236 $129.49 329
2014 Q3 52,842,225 $6,798,751,692 +$110,623,362 $128.65 316
2014 Q2 52,197,884 $4,620,244,446 -$147,923,232 $88.49 302
2014 Q1 53,760,278 $5,055,784,054 -$116,189,342 $94.03 305